CD33 (Siglec-3) Inhibitory Function: Role in the NKG2D/DAP10 Activating Pathway

CD33 (siglec-3), a well-known target in leukemia therapy, is an inhibitory sialoadhesin expressed in human leukocytes of the myeloid lineage and some lymphoid subsets, including NK cells. It may constitute a control mechanism of the innate immune system; nevertheless, its role as an inhibitory recep...

Descripción completa

Detalles Bibliográficos
Autores principales: Hernández-Caselles, Trinidad, Miguel, Rubén Corral-San, Ruiz-Alcaraz, Antonio José, García-Peñarrubia, Pilar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6501159/
https://www.ncbi.nlm.nih.gov/pubmed/31143782
http://dx.doi.org/10.1155/2019/6032141

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6501159/
https://www.ncbi.nlm.nih.gov/pubmed/31143782
http://dx.doi.org/10.1155/2019/6032141

Ejemplares similares